- Home
- ADCT vs HIX Comparison
ADCT vs HIX Comparison
Compare ADCT & HIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADCT
- HIX
- Stock Information
- Founded
- ADCT 2011
- HIX 1998
- Country
- ADCT Switzerland
- HIX United States
- Employees
- ADCT N/A
- HIX N/A
- Industry
- ADCT Biotechnology: Pharmaceutical Preparations
- HIX Finance/Investors Services
- Sector
- ADCT Health Care
- HIX Finance
- Exchange
- ADCT Nasdaq
- HIX Nasdaq
- Market Cap
- ADCT 398.2M
- HIX 384.6M
- IPO Year
- ADCT 2020
- HIX N/A
- Fundamental
- Price
- ADCT $3.33
- HIX $4.34
- Analyst Decision
- ADCT Strong Buy
- HIX
- Analyst Count
- ADCT 6
- HIX 0
- Target Price
- ADCT $7.80
- HIX N/A
- AVG Volume (30 Days)
- ADCT 711.4K
- HIX 449.5K
- Earning Date
- ADCT 11-06-2025
- HIX 01-01-0001
- Dividend Yield
- ADCT N/A
- HIX 13.14%
- EPS Growth
- ADCT N/A
- HIX N/A
- EPS
- ADCT N/A
- HIX N/A
- Revenue
- ADCT $77,246,000.00
- HIX N/A
- Revenue This Year
- ADCT $12.71
- HIX N/A
- Revenue Next Year
- ADCT $6.59
- HIX N/A
- P/E Ratio
- ADCT N/A
- HIX N/A
- Revenue Growth
- ADCT 15.73
- HIX N/A
- 52 Week Low
- ADCT $1.05
- HIX $4.16
- 52 Week High
- ADCT $3.97
- HIX $5.08
- Technical
- Relative Strength Index (RSI)
- ADCT 56.37
- HIX 57.82
- Support Level
- ADCT $3.04
- HIX $4.27
- Resistance Level
- ADCT $3.59
- HIX $4.32
- Average True Range (ATR)
- ADCT 0.17
- HIX 0.03
- MACD
- ADCT 0.03
- HIX 0.00
- Stochastic Oscillator
- ADCT 55.65
- HIX 70.00
About ADCT ADC Therapeutics SA
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's FDA-approved and marketed product, ZYNLONTA (loncastuximab tesirine), is a CD19-directed antibody and alkylating agent conjugate indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. In addition, it also has various other product candidates in its pipeline, such as ADCT-602, Claudin-6, PSMA, NaPi2b, and ASCT2. Geographically, the company generates maximum revenue from the United States, followed by Europe, the Middle East and Africa (EMEA).
About HIX Western Asset High Income Fund II Inc.
Western Asset High Income Fund II Inc is a diversified closed-end management investment company. Its investment objective is to maximize current income by investing at least 80% of its net assets and borrowings for investment purposes in high-yield debt securities.